Duvelisib inhibition of chemokines in patients with CLL (DUO study) and iNHL (DYNAMO study).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David T. Weaver, Kam Sprott, Jonathan Pachter, Ngocdiep T. Le, Matthew Steven Davids, Marco Montillo, Árpád Illés, Gabriel Etienne, Julio Delgado, Bryone J. Kuss, Constantine Tam, Fritz Offner, Scott D. Lunin, Francesc Bosch, Peter Hillmen, Nicole Lamanna, Stephan Stilgenbauer, Pier Luigi Zinzani, Ian Flinn, Jennifer R. Brown
Institutions: Verastem (United States), Harvard University, Dana-Farber Cancer Institute, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University of Debrecen, Institut Bergonié, Hospital Clínic de Barcelona, Flinders Medical Centre, Peter MacCallum Cancer Centre, Ghent University Hospital, Florida Cancer Specialists & Research Institute, Vall d'Hebron Hospital Universitari, Leeds Teaching Hospitals NHS Trust, Columbia University Irving Medical Center, Universität Ulm, University of Bologna, Sarah Cannon
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891947387